These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9717280)

  • 21. The Tunisian oasis ecosystem is a source of antagonistic Bacillus spp. producing diverse antifungal lipopeptides.
    El Arbi A; Rochex A; Chataigné G; Béchet M; Lecouturier D; Arnauld S; Gharsallah N; Jacques P
    Res Microbiol; 2016 Jan; 167(1):46-57. PubMed ID: 26428248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-fungal potentials of extracellular metabolites of Western Ghats isolated Streptomyces sp. NII 1006 against moulds and yeasts.
    Jayamurthy H; Valappil Sajna K; Dastagar SG; Pandey A
    Indian J Exp Biol; 2014 Nov; 52(11):1138-46. PubMed ID: 25434110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal activity of Bacillus subtilis 355 against wood-surface contaminant fungi.
    Feio SS; Barbosa A; Cabrita M; Nunes L; Esteves A; Roseiro JC; Curto MJ
    J Ind Microbiol Biotechnol; 2004 Jun; 31(5):199-203. PubMed ID: 15197600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The first report of antifungal lipopeptide production by a Bacillus subtilis subsp. inaquosorum strain.
    Knight CA; Bowman MJ; Frederick L; Day A; Lee C; Dunlap CA
    Microbiol Res; 2018 Nov; 216():40-46. PubMed ID: 30269855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal activity of Bacillus sp. isolated from compost.
    Czaczyk K; Stachowiak B; Trojanowska K; Gulewicz K
    Folia Microbiol (Praha); 2000; 45(6):552-4. PubMed ID: 11501422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacereutin, an antifungal antibiotic isolated from metabolites of Bacillus cereus CHU 130.
    Tschen JS; Tseng CN
    Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):258-61. PubMed ID: 2484044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of competition on the production and activity of secondary metabolites in Aspergillus species.
    Losada L; Ajayi O; Frisvad JC; Yu J; Nierman WC
    Med Mycol; 2009; 47 Suppl 1():S88-96. PubMed ID: 19255906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wide-range antifungal antagonism of Paenibacillus ehimensis IB-X-b and its dependence on chitinase and beta-1,3-glucanase production.
    Aktuganov G; Melentjev A; Galimzianova N; Khalikova E; Korpela T; Susi P
    Can J Microbiol; 2008 Jul; 54(7):577-87. PubMed ID: 18641704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the antifungal activity of Acinetobacter baumannii LCH001 in vitro and identification of its antifungal components.
    Liu CH; Chen X; Liu TT; Lian B; Gu Y; Caer V; Xue YR; Wang BT
    Appl Microbiol Biotechnol; 2007 Aug; 76(2):459-66. PubMed ID: 17534613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of iturin A in antibiotics from various strains of Bacillus subtilis.
    Besson F; Peypoux F; Michel G; Delcambe L
    J Antibiot (Tokyo); 1976 Oct; 29(10):1043-9. PubMed ID: 825665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mulberry anthracnose antagonists (iturins) produced by Bacillus amyloliquefaciens RC-2.
    Hiradate S; Yoshida S; Sugie H; Yada H; Fujii Y
    Phytochemistry; 2002 Nov; 61(6):693-8. PubMed ID: 12423891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal activity stability of flaxseed protein extract using response surface methodology.
    Xu Y; Hall C; Wolf-Hall C
    J Food Sci; 2008 Jan; 73(1):M9-14. PubMed ID: 18211360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of an antifungal protein from Bacillus licheniformis HS10.
    Wang Z; Wang Y; Zheng L; Yang X; Liu H; Guo J
    Biochem Biophys Res Commun; 2014 Nov; 454(1):48-52. PubMed ID: 25445597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Azotobacter vinelandii new metabolites with antifungal activity].
    Chetverikov SP; Loginov SN
    Mikrobiologiia; 2009; 78(4):479-83. PubMed ID: 19827712
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of secondary metabolites by Cladosporium resinae (NRL-6437) under different growth media and chemical inducers and their pharmaceutical activity.
    Khan AA; Bacha N; Ahmad B; Bakht J; Lutfullah G; Ali J
    Pak J Pharm Sci; 2017 Sep; 30(5):1617-1624. PubMed ID: 29084681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of peptide antifungal antibiotic and biocontrol activity of Bacillus subtilis.
    Kumar A; Saini P; Shrivastava JN
    Indian J Exp Biol; 2009 Jan; 47(1):57-62. PubMed ID: 19317353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation and characterization of a novel antifungal peptide from Aspergillus niger.
    Gun Lee D; Shin SY; Maeng CY; Jin ZZ; Kim KL; Hahm KS
    Biochem Biophys Res Commun; 1999 Oct; 263(3):646-51. PubMed ID: 10512732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth inhibition of toxigenic fungi by a proteinaceous compound from Streptomyces sp. C/33-6.
    Fulgueira CL; Amigot SL; Magni C
    Curr Microbiol; 2004 Feb; 48(2):135-9. PubMed ID: 15057482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The supernatant of Bacillus pumilus SQR-N43 has antifungal activity towards Rhizoctonia solani.
    Huang X; Yong X; Zhang R; Shen Q; Yang X
    J Basic Microbiol; 2013 Aug; 53(8):657-63. PubMed ID: 23417338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The production of antifungal volatiles by Bacillus subtilis.
    Fiddaman PJ; Rossall S
    J Appl Bacteriol; 1993 Feb; 74(2):119-26. PubMed ID: 8444640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.